Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort

In 2017, the Korean government launched an unprecedentedly large-scaled latent tuberculosis infection (LTBI) screening project which covered more than a million individuals in congregate settings. A total of 1,047,689 participants of source population (n = 2,336,157) underwent LTBI testing from 2017 to 2018. The overall LTBI test uptake rate during this project was 44.8%. Workers in daycare centers (83.5%) and kindergartens (78.9%) showed high participation rate. A total of 1,012,206 individuals with valid results of interferon-gamma release assay (IGRA) were selected to constitute the IGRA cohort. Most of the enrolled participants in the IGRA cohort were in their working age. Approximately, three-quarters of total enrolled population were female. Investigating the LTBI prevalence, stages of LTBI care cascade, natural history of LTBI, efficacy of LTBI treatment and cost-effectiveness of LTBI screening are feasible within this IGRA cohort.

[1]  J. Myong,et al.  Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea , 2020, BMJ Open.

[2]  K. Huh,et al.  Modern History of Tuberculosis in Korea , 2019, Infection & chemotherapy.

[3]  D. Dowdy,et al.  Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries , 2019, PLoS medicine.

[4]  T. H. Nguyen,et al.  Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study , 2018, The Lancet. Infectious diseases.

[5]  O. Park,et al.  Tuberculosis prevention and care in Korea: Evolution of policy and practice , 2018, Journal of clinical tuberculosis and other mycobacterial diseases.

[6]  Richard A. White,et al.  Stratification by interferon-γ release assay level predicts risk of incident TB , 2018, Thorax.

[7]  J. Andrews,et al.  Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. , 2017, The Lancet. Respiratory medicine.

[8]  H. Alsdurf,et al.  The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[9]  Hee-Jin Kang,et al.  Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea , 2016, International journal of epidemiology.

[10]  Peter J Dodd,et al.  The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.

[11]  Tumaini R. Coker,et al.  Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. , 2023, JAMA.

[12]  Francesco Castelli,et al.  Towards tuberculosis elimination: an action framework for low-incidence countries , 2015, European Respiratory Journal.

[13]  C. Dye,et al.  Prospects for tuberculosis elimination. , 2013, Annual review of public health.

[14]  Sung Jin Kim,et al.  Republic of Korea. , 2010, Population policy compendium.

[15]  Mitsuhiro Ushio.  [Amendment of tuberculosis prevention law and prospect of tuberculosis control program]. , 2005, Kekkaku : [Tuberculosis].

[16]  Toru Mori.  [Reform of Japan's NTP and its technical perspectives]. , 2004, Kekkaku : [Tuberculosis].

[17]  T. Mori,et al.  Epidemiological transition of tuberculosis and future agenda of control in Japan: results of the Ad-Hoc National Survey of Tuberculosis 2000. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  J. Starke.  Universal screening for tuberculosis infection. School's out! , 1995, JAMA.

[19]  F. F. Davidson,et al.  Isoniazid chemoprophylaxis of tuberculosis. , 1972, California medicine.

[20]  D. Bell,et al.  Tuberculin Testing in Children , 1945, British medical journal.

[21]  R. Balshaw,et al.  Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study , 2019 .

[22]  M. V. Noordegraaf‐Schouten,et al.  SCIENTIFIC ADVICE Programmatic management of latent tuberculosis infection in the European Union , 2018 .

[23]  J. Stockman.  Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon γ Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country , 2007 .